The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy

被引：0
|
作者：
Sheliyan Raveenthiran
John Yaxley
Troy Gianduzzo
Boon Kua
Louise McEwan
David Wong
Gail Tsang
James MacKean
机构：
[1] Royal Brisbane and Women’s Hospital,Department of Medicine
[2] Wesley Urology Clinic,undefined
[3] University of Queensland,undefined
[4] Brisbane Prostate Clinic,undefined
[5] Wesley Medical Imaging,undefined
[6] Genesis Cancer Care,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：385 / 390
页数：5
相关论文
共 50 条
  • [1] The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy
    Raveenthiran, Sheliyan
    Yaxley, John
    Gianduzzo, Troy
    Kua, Boon
    McEwan, Louise
    Wong, David
    Tsang, Gail
    MacKean, James
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (03) : 385 - 390
  • [2] The use of 68Ga-PSMA PET/CT following radical prostatectomy for suspected biochemically recurrent disease
    Raveenthiran, S.
    Yaxley, J.
    Yaxley, A.
    Coughlin, G.
    Yaxley, W.
    Gianduzzo, T.
    Kua, B.
    Pokorny, M.
    McEwan, L.
    Wong, D.
    BJU INTERNATIONAL, 2019, 123 : 24 - 25
  • [3] The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma
    Sheliyan Raveenthiran
    Rachel Esler
    John Yaxley
    Sam Kyle
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 2280 - 2288
  • [4] The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma
    Raveenthiran, Sheliyan
    Esler, Rachel
    Yaxley, John
    Kyle, Sam
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (11) : 2280 - 2288
  • [5] The Use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma
    Raveenthiran, S.
    Esler, R.
    Yaxley, J.
    BJU INTERNATIONAL, 2019, 123 : 81 - 81
  • [6] 68Ga-PSMA-PET/CT as a changing practice tool in biochemically recurrent prostate cancer
    Domingues, P. M.
    Abreu, T.
    Siqueira, M. B.
    Marinho, G.
    Rosa, D.
    Cottas, H.
    Araujo, L. H.
    Herchenhorn, D.
    Peixoto, F. A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] Patterns of disease for biochemically recurrent prostate cancer following radiotherapy
    Raveenthiran, S.
    Yaxley, J.
    Nouhaud, F.
    Yaxley, A.
    Mackean, J.
    Tsang, G.
    McEwan, L.
    Wong, D.
    BJU INTERNATIONAL, 2019, 123 : 24 - 24
  • [8] Prospective comparison of hybrid 68Ga-PSMA PET/CT and PET/MR in patients with biochemically recurrent prostate cancer
    Jentjens, S.
    Mai, C.
    De Coster, L.
    Bidakhvidi, N. Ahmadi
    Mertens, N.
    Everaerts, W.
    Joniau, S.
    Oyen, R.
    Van Laere, K.
    Goffin, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S445 - S445
  • [9] 68Ga-PSMA PET/MRI for the diagnosis of primary and biochemically recurrent prostate cancer: A meta-analysis
    Wang, Rang
    Shen, Guohua
    Yang, Ruoning
    Ma, Xuelei
    Tian, Rong
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 130
  • [10] Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer
    Hope, Thomas A.
    Aggarwal, Rahul
    Chee, Bryant
    Tao, Dora
    Greene, Kirsten L.
    Cooperberg, Matthew R.
    Feng, Felix
    Chang, Albert
    Ryan, Charles J.
    Small, Eric J.
    Carroll, Peter R.
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (12) : 1956 - 1961
12345